Both in Pharmaceuticals
KALA BIO vs Aprea Therapeutics
Over the past year KALA returned −99.5% and APRE returned −49.0%; their daily moves had a correlation of 0.14.
KALA −99.5% APRE −49.0%Growth of $1, one year, split-adjusted
| Metric | KALA | APRE |
|---|---|---|
| Price | $0.5033 | $0.7696 |
| Market cap | $9.7M | $9.7M |
| Today | +11.79% | +2.37% |
| 1 month | −27.1% | −8.2% |
| 6 months | −94.1% | +4.1% |
| Year to date | −98.2% | −9.8% |
| 1 year | −99.9% | −47.3% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 1,868.9× |
| Net cash | $7.2M | $41.2M |
| Dividend yield | — | — |
| Volatility (60d) | 118.7% | 77.4% |
| Short % of float | 2.7% | 6.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).